Higher dose alglucosidase alfa is associated with improved overall survival in infantile-onset Pompe disease (IOPD): data from the Pompe RegistryPriya S. Kishnani, Yin‐Hsiu Chien, Juan Clinton Llerena et al.|Orphanet Journal of Rare Diseases|2023Cited by 16
Insights into immunogenicity and therapeutic strategies to mitigate the immune response in infantile-onset Pompe disease: a comprehensive systematic literature reviewPriya S. Kishnani, Nadia Daba, Johanna M. P. van den Hout et al.|Frontiers in Immunology|2026Cited by 3